Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.

  title={Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.},
  author={Bo Yuan and Jing He and Keishi Kisoh and Hideki Hayashi and Sachiko Tanaka and Nan Si and Haiyu Zhao and Toshihiko Hirano and Baolin Bian and Norio Takagi},
  journal={Oncology reports},
  volume={36 3},
The growth inhibitory effects of bufadienolide compounds were investigated in two intractable cancer cells, a human glioblastoma cell line U-87 and a pancreatic cancer cell line SW1990. Among four bufadienolide compounds, a dose-dependent cytotoxicity was observed in these cancer cells after treatment with gamabufotalin and arenobufagin. The IC50 values of the two compounds were 3-5 times higher in normal peripheral blood mononuclear cells (PBMCs) than these values for both cancer cell lines… 

Figures from this paper

Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87

The results indicate that the two drugs exhibited distinct cytotoxicity against cancerous glial cells with high potency and selectivity, suggesting that growth inhibition associated with G2/M phase arrest and/or necrosis were attributed to their toxicities.

Enhanced Cytotoxic Effects of Arenite in Combination with Active Bufadienolide Compounds against Human Glioblastoma Cell Line U-87

The cytotoxicity of a trivalent arsenic derivative combined with arenobufagin or gamabufotalin was evaluated in human U-87 glioblastoma cells, and findings may provide fundamental insight into the clinical application of the combined regimen for gliOBlastoma.

Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines

Developing a possible strategy composed of AsIII, gamabufotalin, and a p38 MAPK inhibitor may provide novel insight into approaches designed to combat glioblastoma.

Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells

Potential usefulness of both Helle and Areno are suggested in developing therapeutic strategies to treat patients with different types of breast cancer, especially ER-positive breast cancer.

Differentiation induction of human breast cancer cells by arsenite in combination with tetrandrine.

The Erk signaling pathway may be crucially involved in the differentiation induction of breast cancer cells in vitro and in vivo, and the combination of AsIII and Tetra can probably serve as promising candidates for the development of novel therapeutic approaches for different types of breast cancers.

Natural products and their derivatives: Promising modulators of tumor immunotherapy

A deep generalization, analysis, and summarization of the previous achievements, recent progress, and the bottlenecks in the development of natural products as tumor immunotherapy are performed.

Cardiac Glycosides as Immune System Modulators

This review aims to summarize current knowledge in the field of immunomodulatory properties of CGs and emphasize the large area of potential clinical use of these compounds.

Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents.

The molecular mechanisms underlying its multiple pharmacological effects, especially focusing on cancer chemoprevention are highlighted, and possible strategies to develop anticancer therapy by combining flavonoids nutraceuticals and conventional chemotherapeutic agents are discussed.

Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies

As this report shows, immunogenic cell death has been gaining importance in antitumor therapy and should be studied in depth as well as taking into account other applications that may arise from this immune phenomenon.



Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.

  • P. YinXuan Liu Qi Li
  • Biology, Medicine
    Asian Pacific journal of cancer prevention : APJCP
  • 2012
Results of multiple studies indicate that bufalin has marked anti-tumor activities through its ability to induce apoptosis, and large-scale randomized, double-blind, placebo or positive drug parallel controlled studies are now required to confirm the efficacy and apoptosis-inducing potential of bufalin in various cancers in the cliniucal setting.

Bufalin Induces Lung Cancer Cell Apoptosis via the Inhibition of PI3K/Akt Pathway

It is demonstrated thatbufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway and suggested that bufalin is a potential regimen for combined chemotherapy to overcome the resistance of lung cancer cells to chemotherapeutics induced apoptosis.

Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells.

It is revealed that various bufadienolides, including gamabufotalin rhamnoside (1a), bufotalin (2a), and hellebrin (3a), displayed higher growth inhibitory activities for various human cancer cell lines when compared to ouabain and digoxin.

Bufalin Induces the Apoptosis of Acute Promyelocytic Leukemia Cells via the Downregulation of Survivin Expression

Bufalin is a potential regimen to be used in combination with conventional chemotherapeutic drugs to improve acute promyelocytic leukemia therapy and synergized with PD98059 to inhibit the proliferation and induce the apoptosis of NB4 cells.

Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts.

The results provide direct evidence that the expression levels of AQP9, rather than other biomarkers such as cell surface markers and chromosomal alterations, correlate closely with the sensitivity to ATO in both APL cell lines and primary blasts.

Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.

The underlying antineoplastic mechanisms of arenobufagin that involve cross talk between apoptosis and autophagy via inhibition of the PI3K/Akt/mTOR pathway are elucidated.

Immunomodulatory effects of cinobufagin isolated from Chan Su on activation and cytokines secretion of immunocyte in vitro

Results indicated that CBG had potential immune system regulatory effects and suggested that this compound could be developed as a novel immunotherapeutic agent to treat immune-mediated diseases such as cancer.

Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor‐infiltrating lymphocytes, tumor‐draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer

The accumulation of Th 17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.